| Dr Terry Polon Prince, MD | |
|
250 Toll Gate Rd, Warwick, RI 02886-4411 | |
| (401) 921-2900 | |
| (401) 921-2366 |
| Full Name | Dr Terry Polon Prince |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 27 Years |
| Location | 250 Toll Gate Rd, Warwick, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467416933 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | MD12034 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension St John Hospital | Detroit, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eastpointe Radiologists Pc | 7618876327 | 61 |
News Archive
Rosemary Higgins, Associate Dean for Research, College of Health and Human Services, and Germaine Buck Louis, Dean, CHHS, received $1,457,607 from the National Institutes of Health for: "ECHO Consortium on Perinatal Programming of Neurodevelopment."
A new paper published in Regulatory Toxicology and Pharmacology, co-authored by the Physicians Committee for Responsible Medicine, calls for ongoing development and regulatory acceptance of adverse outcome pathways (AOPs), a framework for improving chemical hazard assessment by prioritizing modern test methods that reduce animal use.
Eli Lilly and Company will present data from more than 25 studies at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Ill. from June 1 – 5, 2012, including overall survival results from PARAMOUNT, a Phase III study of an ALIMTA (pemetrexed for injection)-based continuation maintenance regimen for the treatment of advanced nonsquamous non-small cell lung cancer.
Their research suggests that emergency physicians should counsel with other physicians against discharge when they feel strongly about a patient for whom there is no compelling data, other than our evaluation and judgment, Chandra said.
› Verified 4 days ago
| Entity Name | Eastpointe Radiologists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881642056 PECOS PAC ID: 7618876327 Enrollment ID: O20150608000533 |
News Archive
Rosemary Higgins, Associate Dean for Research, College of Health and Human Services, and Germaine Buck Louis, Dean, CHHS, received $1,457,607 from the National Institutes of Health for: "ECHO Consortium on Perinatal Programming of Neurodevelopment."
A new paper published in Regulatory Toxicology and Pharmacology, co-authored by the Physicians Committee for Responsible Medicine, calls for ongoing development and regulatory acceptance of adverse outcome pathways (AOPs), a framework for improving chemical hazard assessment by prioritizing modern test methods that reduce animal use.
Eli Lilly and Company will present data from more than 25 studies at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Ill. from June 1 – 5, 2012, including overall survival results from PARAMOUNT, a Phase III study of an ALIMTA (pemetrexed for injection)-based continuation maintenance regimen for the treatment of advanced nonsquamous non-small cell lung cancer.
Their research suggests that emergency physicians should counsel with other physicians against discharge when they feel strongly about a patient for whom there is no compelling data, other than our evaluation and judgment, Chandra said.
› Verified 4 days ago
| Entity Name | University Hospitals Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669499414 PECOS PAC ID: 4789682493 Enrollment ID: O20190328002134 |
News Archive
Rosemary Higgins, Associate Dean for Research, College of Health and Human Services, and Germaine Buck Louis, Dean, CHHS, received $1,457,607 from the National Institutes of Health for: "ECHO Consortium on Perinatal Programming of Neurodevelopment."
A new paper published in Regulatory Toxicology and Pharmacology, co-authored by the Physicians Committee for Responsible Medicine, calls for ongoing development and regulatory acceptance of adverse outcome pathways (AOPs), a framework for improving chemical hazard assessment by prioritizing modern test methods that reduce animal use.
Eli Lilly and Company will present data from more than 25 studies at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Ill. from June 1 – 5, 2012, including overall survival results from PARAMOUNT, a Phase III study of an ALIMTA (pemetrexed for injection)-based continuation maintenance regimen for the treatment of advanced nonsquamous non-small cell lung cancer.
Their research suggests that emergency physicians should counsel with other physicians against discharge when they feel strongly about a patient for whom there is no compelling data, other than our evaluation and judgment, Chandra said.
› Verified 4 days ago
| Entity Name | Highlands Hospital And Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447443957 PECOS PAC ID: 2769460757 Enrollment ID: O20210806000567 |
News Archive
Rosemary Higgins, Associate Dean for Research, College of Health and Human Services, and Germaine Buck Louis, Dean, CHHS, received $1,457,607 from the National Institutes of Health for: "ECHO Consortium on Perinatal Programming of Neurodevelopment."
A new paper published in Regulatory Toxicology and Pharmacology, co-authored by the Physicians Committee for Responsible Medicine, calls for ongoing development and regulatory acceptance of adverse outcome pathways (AOPs), a framework for improving chemical hazard assessment by prioritizing modern test methods that reduce animal use.
Eli Lilly and Company will present data from more than 25 studies at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Ill. from June 1 – 5, 2012, including overall survival results from PARAMOUNT, a Phase III study of an ALIMTA (pemetrexed for injection)-based continuation maintenance regimen for the treatment of advanced nonsquamous non-small cell lung cancer.
Their research suggests that emergency physicians should counsel with other physicians against discharge when they feel strongly about a patient for whom there is no compelling data, other than our evaluation and judgment, Chandra said.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Terry Polon Prince, MD 250 Toll Gate Rd, Warwick, RI 02886-4411 Ph: (401) 921-2900 | Dr Terry Polon Prince, MD 250 Toll Gate Rd, Warwick, RI 02886-4411 Ph: (401) 921-2900 |
News Archive
Rosemary Higgins, Associate Dean for Research, College of Health and Human Services, and Germaine Buck Louis, Dean, CHHS, received $1,457,607 from the National Institutes of Health for: "ECHO Consortium on Perinatal Programming of Neurodevelopment."
A new paper published in Regulatory Toxicology and Pharmacology, co-authored by the Physicians Committee for Responsible Medicine, calls for ongoing development and regulatory acceptance of adverse outcome pathways (AOPs), a framework for improving chemical hazard assessment by prioritizing modern test methods that reduce animal use.
Eli Lilly and Company will present data from more than 25 studies at the 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, Ill. from June 1 – 5, 2012, including overall survival results from PARAMOUNT, a Phase III study of an ALIMTA (pemetrexed for injection)-based continuation maintenance regimen for the treatment of advanced nonsquamous non-small cell lung cancer.
Their research suggests that emergency physicians should counsel with other physicians against discharge when they feel strongly about a patient for whom there is no compelling data, other than our evaluation and judgment, Chandra said.
› Verified 4 days ago
Marcelle L Piccolello, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 125 Metro Center Blvd Ste 2000, Warwick, RI 02886 Phone: 401-432-2520 Fax: 401-453-8220 | |
David W Rowe, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 401-737-7010 | |
Dr. Anthony G Bruzzese, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 300 Toll Gate Rd, Ste 101a, Warwick, RI 02886 Phone: 401-738-3100 Fax: 401-738-8505 | |
Dr. Robert C Ward, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 125 Metro Center Blvd Ste 2000, Warwick, RI 02886 Phone: 401-432-2500 Fax: 401-453-8220 | |
Jeffrey D Potter, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 31 Bay Lawn Ave, Warwick, RI 02888 Phone: 401-941-6162 | |
Gaurav Jindal, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 125 Metro Center Blvd Ste 2000, Warwick, RI 02886 Phone: 401-432-2500 Fax: 401-921-9212 | |
Hanan Ibrahim Khalil, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 125 Metro Center Blvd Ste 2000, Warwick, RI 02886 Phone: 401-432-2520 Fax: 401-453-8220 |